Prelude Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,231
Closed -$548K 1246
2024
Q4
$548K Buy
+10,231
New +$548K 0.03% 480